StreetAlpha.app
Home › Stocks › ABT

Abbott Laboratories (ABT)

Healthcare
$103.00
▼ −0.84%
LAST CLOSE · NOV 20

Abbott makes pharmaceuticals, diagnostic tests, nutritional products, and medical devices for healthcare providers and consumers. It last closed at $103.00 on Nov 20, down 0.84% on the day. The next earnings report for ABT is expected around Thu, Jan 21, 2027. For the quarter ended Sep 2026, ABT reported EPS of $0.53 on revenue of $13.01B, with revenue up 14.5% from a year ago. Over its last 8 reports the stock moved an average of 5.5% the session after earnings. Over the last 12 months ABT insiders bought $4.4M of stock on the open market and sold $47.9M, according to SEC Form 4 filings.

AI Auto Pilots
Is ABT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ABT.

Key Stats

Last 12 months
Results
Revenue
$48.2B
+10.0% vs a year ago
Net income
$4.7B
−66.4% vs a year ago
EPS (diluted)
$2.69
−66.2% vs a year ago
Free cash flow
$6.8B
14.0% margin
Valuation
Market cap
$178B
1.73B shares
P/E
38.3
Price over 12 month EPS
Price to sales
3.7
Market cap over revenue
Dividend yield
2.45%
$2.52 a share over 12 months
Balance sheet
Cash & equivalents
$4.1B
At Sep 30
Debt
$31.2B
At Sep 30
Shareholder equity
$51.0B
Buybacks
$1.5B
Last 12 months
CEORobert Ford
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $43.1B$43.1BFY2021FY2022: $43.7B$43.7BFY2022FY2023: $40.1B$40.1BFY2023FY2024: $42.0B$42.0BFY2024FY2025: $44.3B$44.3BFY2025

From ABT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Jan 21
Estimated date · Time not announced
Reported EPS
$0.53
Quarter ended Sep 2026
Year ago EPS
$0.94
−43.6% on a GAAP basis
Revenue
$13.01B
+14.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $5.26Dec '24Mar 2025: $0.76Mar '25Jun 2025: $1.01Jun '25Sep 2025: $0.94Sep '25Dec 2025: $1.02Dec '25Mar 2026: $0.61Mar '26Jun 2026: $0.53Jun '26Sep 2026: $0.53Sep '26Latest $0.53
Revenue by quarter
Dec 2024: $10.97BDec '24Mar 2025: $10.36BMar '25Jun 2025: $11.14BJun '25Sep 2025: $11.37BSep '25Dec 2025: $11.46BDec '25Mar 2026: $11.16BMar '26Jun 2026: $12.59BJun '26Sep 2026: $13.01BSep '26Latest $13.01B
How ABT moved after its last 8 reports
Average move the session after a report ±5.5%
Oct 21, 2026Time not announced−1.9%
Jul 16, 2026Time not announced+10.7%
Apr 16, 2026Time not announced−6.0%
Jan 22, 2026Time not announced−10.0%
Oct 15, 2025Time not announced−2.9%
Jul 17, 2025Time not announced−8.5%
Apr 16, 2025Time not announced+2.8%
Jan 22, 2025Time not announced+0.8%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ABTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on ABT: 1 upgrade, 0 downgrades, 0 initiations
Leerink PartnersUpgrade
Nov 21Outperform 

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on ABT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ABT

Technical Analysis

ABT · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 4% below its 20 day and 1% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 42). The nearest support is the swing low (Jul 31) at $102.89, and the nearest resistance the Pivot at $103.77.

Short trendNeutral
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 2.8%/day
Key levels
$129.8552 week high+26.1%
$107.4820 day average+4.3%
$104.73Pivot R1+1.7%
$104.60100 day average+1.6%
$104.54Swing high (Sep 22)+1.5%
$103.8950 day average+0.9%
$103.77Pivot+0.7%
$103.00Last close
$102.89Swing low (Jul 31)−0.1%
$102.03Pivot S1−0.9%
$101.45200 day average−1.5%
$81.9752 week low−20.4%
Indicators
RSI (14)41.89Middle of its rangeNeutral
MACD0.11Below its signal lineBearish
Stochastic4.9Near the bottom of its rangeOversold
ADX (14)17.0No clear trend
Williams %R-98.6Oversold below −80, overbought above −20Oversold
CCI (20)-86.0Oversold below −100, overbought above 100Neutral
Rate of change−6.3%Change over 10 sessionsBearish
ATR (14)$2.91Typical daily range, 2.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for ABT

What happened before

See how ABT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ABT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ABT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ABTHow many large options trades hit ABT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

ABT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●1,396 buying vs 1,272 selling
  • ▼Held by funds -1.3 pts
  • ▲Funds holding +59
  • ▼Superinvestors: 1 added, 4 cut
  • ▲Put/call 1.56 to 1.06
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding3,0462,987+2.0%
In funds' top 102722+22.7%
Held by funds78.5%79.8%−1.3 pts
New / increased216 / 1,180152 / 1,037+17.4%
Reduced / sold out1,147 / 1251,372 / 283−23.1%
Put/call ratio1.061.56−32.3%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ABT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ABT Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$4.4M5 buys · 4 insiders
Sold$47.9M11 sales · 7 insiders
Cluster buy: 3 insiders bought $1.3M between Apr 23 and May 7.
2026-01 bought $2.0M2026-02 bought $1.1M2026-03 sold $485K2026-04 bought $1.1M2026-05 bought $174K2026-08 sold $46.8M2026-09 sold $3K2026-11 sold $406KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 5Mary K MorelandExecutive Vice PresidentSale3,500$116.00$406K
Sep 2John A. Mccoy Jr.Vice President And ControllerSale27$109.54$3K
Aug 25Robert B FordChairman And CEOSale398,832$115.85$46.2M
Aug 11Louis H. MorroneExecutive Vice PresidentSale5,850$109.83$643K
May 7John G StrattonDirectorBuy2,000$86.82$174K
Apr 27Daniel J StarksDirectorBuy10,000$92.65$927K
Every insider buy and sale for ABT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ABT insider trades →

From SEC Form 4 filings by ABT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

ABT Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$1.5B
0.9% yield
Left in program
$5.6B
3.2% of value
Shares outstanding, 12 months
−0.4%
Fewer shares
Last quarter
$0
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
#131 of 358
 
Spent each quarter, last 3 yearsTop bar $1.0B
Dec 2023: $300.0M, average price $108.22Mar 2024: $0Jun 2024: $0Sep 2024: $750.0M, average price $107.05Dec 2024: $365.9M, average price $114.69Mar 2025: $0Jun 2025: $0Sep 2025: $302.5M, average price $124.76Dec 2025: $301.1M, average price $128.68Mar 2026: $0Jun 2026: $1.0B, average price $89.70Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABT is in one of them and how their past ABT trades turned out.

ABT in the AI portfolios
Loading…

ABT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ABT in an article yet. Here's the latest on the wider market.

ABT in the news

ABT Congress Trades

All congress trades →
Trades, 12 months
30
Buys
11
37%
Sells
18
60%
People
14
Last filed Nov 5
Who traded ABT · since 2013
Latest 5 filings of 164
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
Thomas KeanSell (partial)
$1K – $15KTraded Sep 17, 2026Filed Oct 30, 2026
$50K – $100KTraded Oct 2, 2026Filed Oct 27, 2026
$1K – $15KTraded Sep 18, 2026Filed Oct 12, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 7, 2026Nov 5, 202629 d
Thomas KeanR · NJSell (partial)$1K – $15KSep 17, 2026Oct 30, 202643 d
Pete SessionsR · TXSell$50K – $100KOct 2, 2026Oct 27, 202625 d
Gilbert CisnerosD · CABuy$1K – $15KSep 18, 2026Oct 12, 202624 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Abbott Laboratories

Abbott is a health care company based in Abbott Park, Illinois. It develops, makes, and sells products in four main areas: established pharmaceutical products, diagnostic systems and tests, nutritional products, and medical devices. Its customers include hospitals, clinics, laboratories, pharmacies, wholesalers, healthcare providers, government agencies, and consumers, and it sells in markets around the world.

Headquarters
Abbott Park, IL
Founded
1888